Showing 1 results

Archival description
[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.
[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.